Although autograft is still perceived as the
gold-standard material in bone grafting, the wide array of alternatives
available in the market has resulted in a gradual shift towards increased
adoption of bone grafts and substitutes (BGS), especially in the US and
European markets. In contrast to the general picture in developed countries,
autograft bone still represents the most popular option during bone grafting in
the Asia-Pacific (APAC) region and South America.
The report identifies and analyzes the key companies
shaping and driving the global BGS market. The report provides insight into the
competitive BGS landscape, including new companies entering the market and
pipeline products in development. This report is built using data and
information sourced from proprietary databases, secondary sources and primary
research interviews and survey with leading cardiologists, with in-house
analysis conducted by Publisher’s team of industry experts.
Scope
- Investigation of current and future market competition for BGS.
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using BGS devices in clinical practice.
Reasons to buy
- Gain a high level view of the trends shaping and driving the BGS market for coronary applications and peripheral applications in the lower extremity.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
Spanning
over 122 pages, 84 Tables And 3 Figures “Bone
Grafts and Substitutes - Current and Future Players” report provide Clinical
Outcomes, Competitive Assessment, Pipeline Products, Clinical Trials to Watch,
Current and Future Players, Appendix. The Report Cover 16 Companies - Alphatec
Spine, AlloSource, Bacterin, Biomet, DePuy Synthes, Exactech, Globus Medical,
Integra LifeSciences, Medtronic, NuVasive, Olympus Biotech, Orthofix, RTI
Surgical, Stryker, Wright Medical, Zimmer Holdings.
Inquiry for more information
visit:
For regular industry updates
subscribe to our newsletter at:
No comments:
Post a Comment
Note: only a member of this blog may post a comment.